United Nations Sustainable Development Goals Index

End poverty in all its forms everywhere.

• Between 2017 and early 2022, Elanco’s East Africa Growth Accelerator (EAGA) initiative helped improve the productivity of more than 273,000 small-scale livestock producers by distributing high-quality, affordable veterinary products in adjusted small pack sizes, facilitating access to feed additives and educating small producers.
• Based on the success of EAGA, in 2022 Elanco and GalvMed (The Global Alliance for Livestock Veterinary Medicine), partnered to create “Managing Animal Health and Acaricides for a Better Africa” (MAHABA) which is designed to support small-scale producers by defining and implementing strategies to effectively manage tick infestations in cattle.

Elanco Shared Value Initiatives Web Page

2022 ESG Report: pgs 21-22

Farmer and Producer Livelihoods Issue Brief

End hunger, achieve food security and improved nutrition and promote sustainable agriculture.

Target 2.3: By 2030, double the agricultural productivity and incomes of small-scale food producers, in particular women, Indigenous peoples, family farmers, pastoralists, and fishers, including through secure and equal access to land, other productive services, markets and opportunities for value addition and non-farm employment.

Target 2.4: By 2030, ensure sustainable food production systems and implement resilient agriculture practices that increase productivity and production, that help maintain ecosystems, which strengthen capacity for adaptation to climate change, extreme weather, drought, flooding and other disasters and that progressively improve land and soil quality.

• We make a meaningful contribution to SDG 2 Target 2.3 through our prior East Africa Growth Accelerator (EAGA) and current Managing Animal Health and Acaricides for a Better Africa (MAHABA) initiatives in Africa, as we aim to educate and improve the productivity of small-scale producers through informational resources and access to animal health products.
• Numerous Elanco products and services align with Target 2.4 by improving the sustainability of animal agriculture. We work with farmers, veterinarians and other stakeholders to provide innovative solutions that help to improve animal health and welfare, while also reducing the environmental impact of livestock production. Our approach is based on a deep understanding of the complex interactions between animals, humans and the environment – and we are constantly striving to develop new technologies and practices that promote sustainable agriculture and enhance the resilience of farming communities around the world. Through our efforts, we aim to progressively secure food supply for future generations.

Elanco Shared Value Initiatives Web Page

2022 ESG Report: pgs 14-15, 21-22, 36-38

Farmer and Producer Livelihoods Issue Brief

Elanco Animal Products and Services

Ensure healthy lives and promote well-being for all at all ages.

• As a leading advocate for the responsible use of antimicrobials in animal health, instituted a multi-faceted 8-point plan in 2014 to help increase responsible antibiotic stewardship, reduce the need for antibiotics and to replace them with alternatives. We believe it is essential to preserve the effectiveness of antibiotics for both human and animal health. We work tirelessly to promote responsible use of antibiotics in animal agriculture, and we have developed a comprehensive approach to antimicrobial stewardship that includes education, research, and collaboration with stakeholders.
• Elanco is a leading manufacturer of salmonella and rabies vaccines which reduce human vector-borne disease. Salmonella is a common bacterium that can cause food poisoning in humans. By vaccinating animals against salmonella, we can reduce the risk of human exposure and illness. Rabies, on the other hand, is a deadly virus that can be transmitted from animals to humans through bites or scratches. Vaccinating animals against rabies helps protect both animals and humans from this dangerous disease. Elanco is committed to improving the health and well-being of both animals and humans through innovative vaccines and other products.

2022 ESG Report: pgs 18-20

Antimicrobial Stewardship Issue Brief

Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all 

Target 4.4: By 2030, substantially increase the number of youth and adults who have relevant skills, including technical and vocational skills, for employment, decent jobs and entrepreneurship.

Target 4.5: By 2030, eliminate gender disparities in education and ensure equal access to all levels of education and vocational training for the vulnerable, including persons with disabilities, Indigenous peoples and children in vulnerable situations.

• Elanco promotes SDG Target 4.4 through Veterinarian education and self-care support.  We offer a range of resources and tools to help veterinarians manage their well-being, including stress-management techniques, mental health resources, and peer support programs. Additionally, we provide educational opportunities to help veterinarians stay up-to-date on the latest research and best practices, which can help reduce stress and increase job satisfaction.
• Elanco encourages Target 4.5 by partnering with Auburn University College of Veterinary Medicine to provide Fellowships for two individuals pursuing a doctorate in biomedical sciences - the Auburn University Veterinary Business Management Association (VBMA) Fellowship. This program is designed to provide veterinary students with a unique opportunity to gain hands-on experience in business management and entrepreneurship.  
• Elanco Knowledge Solutions is our comprehensive training program designed to help veterinarians, technicians, and other animal health professionals stay up-to-date on the latest research and best practices in the industry. The program includes a variety of online courses and resources that cover topics such as animal health, disease prevention, and treatment options. These courses are developed by experts in the field and are designed to be engaging and interactive, with quizzes and other activities to reinforce learning.

2022 ESG Report: pgs 15, 43

Veterinary Livelihoods Issue Brief

Achieve gender equality and empower all women and girls.

Ensure availability and sustainable management of water and sanitation for all.

Target 6.3: By 2030, improve water quality by reducing pollution, eliminating dumping, and minimizing release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe reuse globally.

Target 6.4: By 2030, substantially increase water-use efficiency across all sectors and ensure sustainable withdrawals and supply of freshwater to address water scarcity and substantially reduce the number of people suffering from water scarcity.

• Elanco Clinton Laboratories supports Target 6.3 through optimized water treatment sufficiently to be able to discharge fresh water to a 3.6 acre parcel planted with native prairie seed mix.  This resulted in the return of over 5 million gallons per year directly to the local water cycle.
• Additionally, Target 6.4 is promoted through the water savings project at the Elanco Clinton Laboratories recently reduced water withdrawal by almost 50% from 2.3 billion gallons to 1.2 billion gallons. In 2023 and beyond, Elanco expects to complete a water scarcity evaluation and establish a global water use reduction target. We also expect to identify additional collaboration opportunities to support ecosystem conservation around the globe.

2022 ESG Report: pg 31

Water Management and Biodiversity Issue Brief

Presentation to State of Indiana - Water and Energy Savings

Ensure access to affordable, reliable, sustianable modern energy for all.

• Elanco has committed to the use of 100% renewable sources of electricity across the company’s operations by 2030.
• We sourced >12% of electricity from renewable sources in 2022.

Promote sustained, inclusive, and sustainable economic growth, full and productive employment and decent work for all.

Target 8.5: By 2030, achieve full and productive employment and decent work for all women and men, including for young people and persons with disabilities, and equal pay for work of equal value.

Target 8.7: Take immediate and effective measures to eradicate forced labor, end modern slavery and human trafficking and secure the prohibition and elimination of the worst forms of child labor, including recruitment and use of child soldiers, and by 2025 end child labor in all its forms.

Target 8.8: Protect labor rights and promote safe and secure working environments for all workers, including migrant workers, in particular women migrants, and those in precarious employment.

• Elanco promotes Target 8.5 by conducting pay-equity analyses for gender and race/ethnicity, annually.
• Additionally, Target 8.7 is supported through our new human rights policy and third-party supply chain monitoring program are key components of this commitment. The policy sets out our expectations for human rights and ethical practices, including our zero-tolerance policy for forced labor. Our third-party supply chain monitoring program helps us identify and address any potential issues related to forced labor or other human rights abuses in our supply chain. By working with our suppliers and other partners, we can take steps to measure and eradicate forced labor, and promote fair and ethical practices throughout the animal health industry.
• In 2023, we are establishing a formal human rights program, including development of a global human rights policy, an executive oversight committee and a core program team including representatives from ESG and sustainability, legal and compliance, HSE, procurement, supply chain and other departments to support Target 8.8. This new policy will reaffirm our support of leading human rights practices as specified in the OECD Guidelines for Multinational Enterprises, the U.N. Guiding Principles on Business and Human Rights (including the International Labour Organization Declaration of Fundamental Principles and Rights at Work) and the Pharmaceutical Supply Chain Initiative Principles for Responsible Supply Chain Management. The policy will outline our commitments and procedures, including due diligence specifications that apply to our own operations, supply chain and other business partners. The policy will also provide a global framework for regional human rights activities, including the management of modern slavery risks specified in modern slavery statements required by several jurisdictions in which we operate.

2022 ESG Report: pgs 40-44

Elanco’s Ethics and Compliance Program Page

Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation 

Target 9.4: By 2030, upgrade infrastructure and retrofit industries to make them sustainable, with increased resource-use efficiency and greater adoption of clean and environmentally sound technologies and industrial processes, with all countries taking action in accordance with their respective capabilities.

Target 9.5: Enhance scientific research, upgrade the technological capabilities of industrial sectors in all countries, in particular developing countries, including, by 2030, encouraging innovation and substantially increasing the number of research and development workers per 1 million people and public and private research and development spending.

• To promote Target 9.4, Elanco is engaging in retrofitting to increase its resource-use efficiency.  
• Elanco, believes that innovation is key to driving progress and improving animal health around the world. In support of Target 9.5, we encourage innovation in all aspects of our business, from research and development to employment and private spending. We invest heavily in research and development to create new products and technologies that can help improve animal health and well-being. We also encourage our employees to be innovative and creative in their work, and we provide opportunities for professional development and training to support this. By fostering innovation, we can create new jobs, drive economic growth, and improve the lives of animals and their owners.

2022 ESG Report: pgs 28-38, 43

Innovation and Intellectual Property Issue Brief

Veterinary Livelihoods Issue Brief

Ensure sustainable consumption and production patterns.

Target 12.3: By 2030, halve per capita global food waste at the retail and consumer levels and reduce food losses along production and supply chains, including post-harvest losses.

Target 12.4: Achieve the environmentally sound management of chemicals and all wastes throughout their life cycle, in accordance with agreed international frameworks, and significantly reduce their release to air, water and soil to minimize their adverse impacts on human health and the environment.

Target 12.5: By 2030, substantially reduce waste generation through prevention, reduction, recycling and reuse.

Target 12.6: Encourage companies, especially large and transnational companies, to adopt sustainable practices and to integrate sustainability information into their reporting cycle.

• Our primary business, improving animal health, contributes markedly to SDG 12 Target 12.3 by helping livestock producers upstream in the food value chain reduce disease-related losses through flea and tick control, vaccinations and nutritious feed additives. This, in turn, can help reduce the amount of food waste that occurs in the animal agriculture industry. When animals are healthy, they are more likely to reach their full potential with less waste.
• We contribute to SDG 12 Targets 12.4 and 12.5 in our manufacturing operations by working to reduce waste generation wherever possible. In addition, Elanco products and services help animal protein producers reduce emissions such as methane and ammonia.
• We contribute to SDG 12 Target 12.6 by demonstrating sustainable internal business practices. We strive to minimize our environmental impact by reducing our energy consumption, waste generation, and carbon footprint. We have implemented recycling programs, energy-efficient lighting and equipment, and water conservation measures across our facilities. Additionally, we prioritize sustainable sourcing and responsible supply chain management to ensure that our products and services are produced and delivered in an environmentally and socially responsible way. We believe that our sustainable practices not only benefit the planet, but also contribute to our long-term success as a company.

2022 ESG Report: pgs 14-15, 18-20, 30, 33-35

Elanco Animal Products and Services

Antimicrobial Stewardship Issue Brief

Farmer and Producer Livelihoods Issue Brief

Waste Management Issue Brief

Take urgent action to combat climate change and its impacts.

Target 13.2: Integrate climate change measures into national policies, strategies and planning.

Target 13.3: Improve education, awareness-raising and human and institutional capacity on climate change mitigation, adaptation, impact reduction and early warning.

• To elevate Target 13.2, Elanco is piloting UpLook™, an insights engine designed to identify key drivers of an operation’s carbon footprint, providing producers with a baseline of their current stewardship efforts.
• Athian’s key mission will be to help the cattle industry capture and claim carbon credits earned through sustainability efforts where possible, primarily by validating and certifying GHG reductions and carbon capture from services like UpLook. Elevating producers’ awareness of the industry impact drives institutional capacity (Target 13.3).

2022 ESG Report: pgs 14, 36-38

Farmer and Producer Livelihoods Issue Brief

Conserve and sustainably use the oceans, seas and marine resources for sustainable development.

• Elanco’s innovative products and services help marine and freshwater aquaculture producers improve welfare, productivity, and sustainability from hatch to harvest. Elanco Aquaculture products can help reduce the risk of disease outbreaks and improve the overall sustainability of the industry. Our products are designed to be safe for the environment, helping to protect marine ecosystems. We believe that by working together with farmers, scientists, and other stakeholders, we can create a more sustainable and responsible aquaculture industry that benefits both animals and the environment.

Elanco Aqua website

2022 ESG Report: pg 32

Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels.

Target 16.2: End abuse, exploitation, trafficking and all forms of violence and torture of children.

Target 16.5: Substantially reduce corruption and bribery in all their forms.

• To support Target 16.2, in 2023, we are establishing a formal human rights program, including development of a global human rights policy, an executive oversight committee and a core program team including representatives from ESG and sustainability, legal and compliance, HSE, procurement, supply chain and other departments. This new policy will reaffirm our commitment to leading human rights practices as specified in the OECD Guidelines for Multinational Enterprises, the U.N. Guiding Principles on Business and Human Rights (including the International.
• Labour Organization Declaration of Fundamental Principles and Rights at Work) and the Pharmaceutical Supply Chain Initiative Principles for Responsible Supply Chain Management. The policy will outline our commitments and procedures, including due diligence specifications that apply to our own operations, supply chain and other business partners.
• The Elanco Ethics and Compliance program integrates anti-corruption policies and internal monitoring practices to reduce/prohibit bribery in all its forms, in support of Target 16.5.

2022 ESG Report: pg 56

Anti-Bribery and Anti-Corruption policy

Elanco Ethics and Compliance Program page

Elanco Modern Slavery Statement – Australia

Elanco Modern Slavery Statement – Norway

Elanco Modern Slavery Statement – U.K.

Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development.

Target 17.3: Mobilize financial resources for developing countries.

Target 17.6: Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism.

Target 17.16: Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals in all countries, in particular developing countries.

• In support of Target 17.3, EAGA and MAHABA mobilize financial resources for developing nations because they are able to generate revenue that can be reinvested in the local area to help it grow and expand. By mobilizing financial resources in this way, we have a greater impact on the lives of farmers and their communities in developing nations.
• Additionally, Target 17.16 is demonstrated by Elanco’s global operations and product markets promote access to science, technology and innovation and Elanco encourages access to technology at the global level by investing in research and development, collaborating with partners, and leveraging our expertise to create innovative solutions that can be scaled and shared across different regions and markets.
• EAGA and MAHABA are also multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources.

Elanco Shared Value Initiatives Web Page

2022 ESG Report: pgs 21-22

Farmer and Producer Livelihoods Issue Brief

Innovation and Intellectual Property Issue Brief